Enteric fever, predominantly caused by Salmonella Typhi and Paratyphi, presents a significant global health challenge, particularly in low-resource settings. This article outlines comprehensive strategies for effective management of enteric fever, with a focus on diagnosis, treatment, and prevention.
Accurate and timely diagnosis is essential for effective management of enteric fever. Blood culture remains the gold standard for diagnosis, although its sensitivity can be low. Rapid diagnostic tests (RDTs) are increasingly used due to their ease of use, but their sensitivity and specificity vary. Molecular techniques, such as PCR, offer promise for future diagnostics but require further validation.
Antibiotic therapy is the cornerstone of enteric fever treatment. However, the emergence of multidrug-resistant strains necessitates a judicious use of antibiotics. Fluoroquinolones, the third-generation cephalosporins and azithromycin are currently recommended for treatment. It is crucial to monitor the local antimicrobial resistance patterns and adapt the treatment strategy accordingly.
Prevention strategies for enteric fever include improved sanitation, safe water supply, and vaccination. Typhoid conjugate vaccines (TCVs), providing longer-term protection and suitable for children under two, have been WHO-prequalified and are recommended for use in endemic areas. However, vaccine coverage remains suboptimal in many regions.
Strengthening healthcare systems is key to managing enteric fever effectively. This includes improving laboratory infrastructure for accurate diagnosis, training healthcare workers in case management, and establishing surveillance systems for monitoring disease burden and antimicrobial resistance.
Effective management of enteric fever requires a comprehensive approach encompassing accurate diagnosis, appropriate treatment, prevention measures, and strengthening of healthcare systems. Given the global burden of this disease, it is imperative for healthcare professionals to stay updated on the latest strategies for enteric fever management.
1.
Stem Cell Selection Unneeded for SSc Transplant Therapy?
2.
Radiation from CT scans could account for 5% of all cancer cases a year, study suggests
3.
Do I have prostate cancer? Why a simple PSA blood test alone won't give you the answer
4.
In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.
5.
Tumor infiltration of major blood vessels, not metastasis, may be primary cause of cancer death
1.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
2.
Emerging Dysregulated Signaling Pathways in Early-Onset Colorectal Cancer
3.
Exploring the Use of Bevacizumab in Treating Different Types of Cancers
4.
A Closer Look at Poorly Differentiated Carcinoma: Uncovering its Complexities
5.
Unlocking the Secrets of Squamous Cell Carcinoma: New Hope for Patients
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
A New Era in Managing Cancer-Associated Thrombosis
4.
Navigating the Complexities of Ph Negative ALL - Part IX
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation